AB-001
N/A
Report date: 2025/07/01 20:00:14
NME
Base Information
Drug NameAB-001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesAbsize
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesVanton Research Laboratory LlcFrontier Biotechnologies IncFrontier Biopharma Company Ltd +[4]
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksWikipedia